Quinoline 3 -sulfonate esters as NK3 receptor modulators

Details for Australian Patent Application No. 2006259890 (hide)

Owner AstraZeneca AB

Inventors Woods, James; Kang, James; Li, Yan; Simpson, R. Thomas; Alhambra, Christobal; Koether, M. Gerard; Albert, S. Jeffrey

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006259890

PCT Pub. Number WO2006/137789

Priority 60/693,281 23.06.05 US

Filing date 21 June 2006

Wipo publication date 28 December 2006

International Classifications

C07D 215/52 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137789 Priority application(s): WO2006/137789

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259891-New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases

2006259886-Method and means for creating fluid transport